Veradigm Inc MDRX
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover MDRX, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.
News
-
VERADIGM ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their Options
-
MDRX INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Reminds Veradigm Investors of a Class Action Lawsuit and Upcoming Deadline
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MDRX
-
Veradigm Inc. investors: Please contact the Portnoy Law Firm to recover your losses; January 22, 2024 deadline
-
MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit
-
VERADIGM SHAREHOLDER UPDATE: Kaplan Fox & Kilsheimer LLP Reminds Veradigm Investors of Upcoming Deadline
-
Veradigm Inc. Announces Leadership Transition
-
VERADIGM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Veradigm Inc. and Encourages Investors to Contact the Firm
Trading Information
- Previous Close Price
- $12.59
- Day Range
- $9.86–12.25
- 52-Week Range
- $9.86–19.14
- Bid/Ask
- $10.02 / $10.28
- Market Cap
- $1.10 Bil
- Volume/Avg
- 8.7 Mil / 1.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Veradigm Inc is a healthcare technology company that drives value through its various combination of platforms, data, expertise, connectivity, and scale. It delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 8,000
- Website
- https://www.veradigm.com
Valuation
|
Metric
|
MDRX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
MDRX
Financial Strength
|
Metric
|
MDRX
|
|---|---|
Quick Ratio | 2.87 |
Current Ratio | 3.20 |
Interest Coverage | 15.00 |
Quick Ratio
MDRX
Profitability
|
Metric
|
MDRX
|
|---|---|
Return on Assets (Normalized) | 7.93% |
Return on Equity (Normalized) | 13.01% |
Return on Invested Capital (Normalized) | 10.79% |
Return on Assets
MDRX
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | Dvdgfc | $31.2 Bil | |
VEEV
| Veeva Systems Inc Class A | Qwnp | $27.8 Bil | |
MTHRF
| M3 Inc | Ckqtlhq | $9.9 Bil | |
MTHRY
| M3 Inc ADR | Smrplrr | $9.9 Bil | |
PMCUF
| Pro Medicus Ltd | Xtpsmx | $6.1 Bil | |
HQY
| HealthEquity Inc | Rqkxb | $5.9 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | Pvhpy | $5.8 Bil | |
DOCS
| Doximity Inc Class A | Lrblxj | $4.6 Bil | |
RCM
| R1 RCM Inc | Vwvc | $4.4 Bil | |
PGNY
| Progyny Inc | Srdgp | $3.5 Bil |